CAS: 1247018-19-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | FGTI-2734 REF: 54-BUP05267CAS: 1247018-19-4 | ≥98% | 586.00 €~1,225.00 € | Wed 30 Apr 25 |
 | FGTI-2734 REF: 3D-XZB01819CAS: 1247018-19-4 | Min. 95% | To inquire | Tue 10 Jun 25 |
 | FGTI-2734 REF: TM-T11282CAS: 1247018-19-4 | 99.36% | 51.00 €~835.00 € | Tue 01 Jul 25 |
Ref: 54-BUP05267
| 25mg | 586.00 € | ||
| 50mg | 862.00 € | ||
| 100mg | 1,225.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
FGTI-2734
CAS:1247018-19-4
Please enquire for more information about FGTI-2734 including the price, delivery time and more detailed …
Formula:
C26H31FN6O2S
Purity:
Min. 95%
Molecular weight:
510.6 g/mol
Ref: 3D-XZB01819
| 10mg | 911.00 € | ||
| 25mg | 1,400.00 € | ||
| 50mg | 2,182.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
FGTI-2734
CAS:1247018-19-4
FGTI-2734, a dual FT/GGT-1 inhibitor (IC50: 250/520 nM), blocks KRAS membrane binding and curbs KRAS-driven …
Formula:
C26H31FN6O2S
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
510.63
Ref: TM-T11282
| 1mg | 51.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 188.00 € | ||
| 25mg | 393.00 € | ||
| 50mg | 587.00 € | ||
| 100mg | 835.00 € | ||
| 1mL*10mM (DMSO) | 136.00 € |
Estimated delivery in United States, on Tuesday 1 Jul 2025
